WPI 858 (Bupropion Extended-Release (SR) 100 mg)
Pill imprint WPI 858 has been identified as Bupropion hydrochloride extended-release (SR) 100 mg.
Bupropion is used in the treatment of sexual dysfunction, ssri induced; major depressive disorder; adhd; depression; anxiety (and more), and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- WPI 858
- 100 mg
- Prescription only
- Drug Class:
- Miscellaneous antidepressants
Smoking cessation agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|54569-5568||A-S Medication Solutions, LLC (repackager)|
|68115-0676||Dispensexpress Inc (repackager)|
|58016-0240||Southwood Pharmaceuticals Inc (repackager)|
|16590-0036||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
More about bupropion
- Bupropion extended-release tablets
- Bupropion hydrobromide extended-release tablets
- Bupropion sustained-release tablets
- Bupropion (Advanced Reading)
Related treatment guides
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.